4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸
中文名称 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 |
---|---|
中文同义词 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸;白细胞粘附素-1 |
英文名称 | Leukadherin 1 |
英文同义词 | Leukadherin 1;Leukadherin-1;4-[5-[[4-Oxo-3-(phenylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-benzoic acid;Leukadhedrin 1;LA1(Leukadherin-1);CS-2237;LEUKADHERIN 1;LEUKADHERIN1;eukadherin-1 |
CAS号 | 344897-95-6 |
分子式 | C22H15NO4S2 |
分子量 | 421.49 |
EINECS号 | |
相关类别 | API |
Mol文件 | 344897-95-6.mol |
结构式 | ![]() |
4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 性质
沸点 | 634.7±65.0 °C(Predicted) |
---|---|
密度 | 1.50±0.1 g/cm3(Predicted) |
储存条件 | Sealed in dry,2-8°C |
溶解度 | DMSO:可溶,3mg/mL,澄清(加热) |
酸度系数(pKa) | 4.11±0.10(Predicted) |
形态 | 粉末 |
颜色 | 黄色到橙色到棕色 |
Leukadherin-1 is a specific agonist of the leukocyte surface integrin CD11b/CD18 (αMβ2; CR3; Mac-1). Leukadherin‐1 pretreatment reduces secretion of interferon (IFN)‐γ, tumour necrosis factor (TNF) and macrophage inflammatory protein (MIP)‐1β by monokine‐stimulated NK cells. Leukadherin‐1 pretreatment also reduces secretion of IL‐1β, IL‐6 and TNF by Toll‐like receptor (TLR)‐2 and TLR‐7/8‐stimulated monocytes.
Leukadherin-1 (1 mg/kg; i.p.; twice daily for 14 days) is beneficial in preventing hyperoxia-induced neonatal lung injury, an experimental model of bronchopulmonary dysplasia (BPD).
Animal Model: | Newborn Sprague Dawley rat pups |
Dosage: | 1 mg/kg |
Administration: | I.p.; twice daily for 14 days |
Result: | Beneficial on preventing the lung inflammatory response, improved alveolarization and vascular development, and reduced pulmonary vascular remodeling and PH in a hyperoxia-induced experimental model of BPD. |
安全信息
WGK Germany | 3 |
---|
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-15701 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 Leukadherin-1 | 344897-95-6 | 5 mg | 450元 |
2024/04/30 | HY-15701 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 Leukadherin-1 | 344897-95-6 | 10mM * 1mLin DMSO | 495元 |